Article Details
Retrieved on: 2021-06-05 05:03:45
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Truist Securities raised their target price on shares of NovoCure from $132.00 to $142.00 and gave the stock a "hold" rating in a report on Monday, ...
Article found on: www.marketbeat.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here